semaglutide and phentermine together for weight loss + Together: Safety & Clinical Consider... – PlexusDx What You Need to Know

It is often described as a triple agonist because it targets GLP-1, GIP, and glucagon pathways

Some of the major market players in the GLP-1 receptor agonist industry include Amgen Inc., Eli Lilly and Company, Hanmi Pharm Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Novo Nordisk A/S, Paige Biomedicine (Suzhou) Co., Ltd., and Sanofi S.A

Be cautious if your provider says "just take what feels right" or recommends adjusting doses without clear milligram targets

It is mostly prescribed for Type 2 Diabetes but is highly effective for weight management

Some physicians prescribe a maintenance dose, a low dose taken long-term to prevent full regain